Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Baxalta Incorporated

http://www.baxalta.com/

Latest From Baxalta Incorporated

ICER Enhanced Patient Engagement Program Will Be Led By Former Biopharma Exec

Yvette Venable has more than 20 years’ experience in patient advocacy, heath policy and biopharma communications.

Health Technology Assessment Leadership

Evotec Extends Takeda Pact to Gene Therapy

Evotec is building a gene therapy R&D center manned by ex-Takeda scientists and has already landed a multi-year drug discovery pact for it with their former Japanese employer.

Companies Deals

Novo Nordisk Halts Phase III Concizumab Hemophilia Trials After Three Thrombotic Events

No new patients will be enrolled, and trial participants will stop treatment with the tissue factor pathway inhibitor antibody, a class with four prior suspended hemophilia programs.

Clinical Trials Drug Safety

Recordati's Isturisa Approved For Cushing's In EU

Acquired from Novartis last year, Isturisa is forecast to have peak sales of over $100m. Now all eyes will be on a PDUFA date in March.

Approvals Rare Diseases
See All

Company Information

  • Other Names / Subsidiaries
    • AesRX LLC
    • Chatham Therapeutics
    • Gambro AB
    • Immuno-US
    • Prism Pharmaceuticals, Inc.
    • SuppreMol GmbH
    • Synovis Life Technologies, Inc.
    • Thunderbolt, Inc.
    • Vitesse Biologics, LLC
UsernamePublicRestriction

Register